Cargando…

Predictive factors of poor outcomes in the COVID-19 epidemic: Consider the inflammatory response

Detalles Bibliográficos
Autores principales:	Razanamahery, J., Malinowski, L., Humbert, S., Brunel, A.S., Lepiller, Q., Chirouze, C., Bouiller, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195007/ https://www.ncbi.nlm.nih.gov/pubmed/32339596 http://dx.doi.org/10.1016/j.medmal.2020.04.016

Ejemplares similares

Does type of immunosupression influence the course of Covid-19 infection?
por: Razanamahery, J., et al.
Publicado: (2020)

COVID-19 as a cause of immune thrombocytopenia
por: Humbert, S., et al.
Publicado: (2020)

Utility of CT scan in patients with initial negative PCR for SARS-CoV2: a report of three cases
por: Bouiller, Kevin, et al.
Publicado: (2020)

Comparaison des scores de sévérité dans les pneumonies à SARS-CoV-2
por: Malinowski, L., et al.
Publicado: (2020)

COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity
por: Kroemer, Marie, et al.
Publicado: (2021)

Facteurs de risque de COVID-19 chez les soignants
por: Lebreton, C., et al.
Publicado: (2020)

Mixed mold infection with Aspergillus fumigatus and Rhizopus microsporus in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient
por: Bellanger, A.-P., et al.
Publicado: (2021)

Poor responders: Is it time to consider changing the nomenclature?
por: Chittawar, Priya Bhave, et al.
Publicado: (2012)

Infection à SARS-CoV-2 de la personne âgée : le score de fragilité est un facteur pronostique
por: Gilis, M., et al.
Publicado: (2020)

We Must Consider a Growing Opioid Epidemic in Older People
por: Hudson, Murray A J, et al.
Publicado: (2022)

Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine
por: Tissot, Noémie, et al.
Publicado: (2021)

Cardiovascular factors predicting poor outcome in COVID-19 patients
por: Mishra, Ajay Kumar, et al.
Publicado: (2020)

Caractéristiques de la COVID-19 chez les patients âgés de 75 ans et plus, hospitalisés
por: Gilis, M., et al.
Publicado: (2020)

SARS CoV-2 vaccine AND rituximab, timing might be a key for a better vaccine response
por: Verhoeven, Frank, et al.
Publicado: (2021)

Letter to the editor in response to ‘Reconstruction and prediction of viral disease epidemics’
por: Perkins, T. Alex
Publicado: (2019)

Nasal or Nasopharyngeal Tuberculosis Should be Considered in the Initial Diagnosis of Sino-Nasal Inflammatory Diseases
por: Min, Hyun Jin, et al.
Publicado: (2017)

How to Manage Disasters while Considering Responsibility to Protect Theory?
por: Esfandiar, Hasan, et al.
Publicado: (2021)

Stopping antiepileptic drugs – other factors to consider
Publicado: (2021)

Response to: “Are women equal? Considering impact of therapeutic abortion bans on science”
por: Áinle, Fionnuala Ní, et al.
Publicado: (2022)

Epidemiology and risk factors of Staphylococcus aureus CC398 bone and joint infections
por: Bouiller, Kevin, et al.
Publicado: (2020)

Consider multisystem inflammatory syndrome in children with kidney failure after SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2022)

Human Infection of Methicillin-Susceptible Staphylococcus aureus CC398: A Review
por: Bouiller, Kevin, et al.
Publicado: (2020)

Asthma and Cacosmia Could Be Predictive Factors of Olfactory Dysfunction Persistence 9 Months after SARS-CoV-2 Infection: The ANOSVID Study
por: Tipirdamaz, Can, et al.
Publicado: (2022)

T-cell response to 3 doses of Sars-Cov2 BNT162b2 Pfizer vaccine in long term rituximab treated patients
por: Heitz, Jade, et al.
Publicado: (2022)

Considering the Appropriateness of the Factor Analytic Operationalization of Allostatic Load
por: Crook, Zander, et al.
Publicado: (2017)

Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab
por: Fink, A M, et al.
Publicado: (2013)

It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window?
por: Ghanei, Mostafa
Publicado: (2021)

Why You Should Consider an Advanced Training Fellowship in Inflammatory Bowel Disease
por: Gallinger, Zane
Publicado: (2017)

Considering the design effect in cluster sampling
por: Alimohamadi, Yousef, et al.
Publicado: (2019)

Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients
por: Mouhat, Basile, et al.
Publicado: (2020)

More Risk Factors of Hepatitis C Transmission Should be Considered in Pakistan
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

ADMA is a useful marker, but many confounding factors should be considered!
por: Balta, Şevket, et al.
Publicado: (2015)

Response to comments on: Optical coherence tomography angiography in epidemic retinitis
por: Reddy, Subhakar, et al.
Publicado: (2021)

Evaluating undercounts in epidemics: Response to Maruotti et al. (2022)
por: Li, Michael, et al.
Publicado: (2023)

Environmental Factors Influencing Epidemic Cholera
por: Gaudart, Jean, et al.
Publicado: (2013)

Institutional factors in the medical burnout epidemic
por: Hauck, Simone, et al.
Publicado: (2019)

Athlete's heart and other entities to consider around
por: Martín, María, et al.
Publicado: (2020)

Methodological notes, should be considered in research on mizaj
por: Farahani, Akram Moradi, et al.
Publicado: (2021)

Reply to Letter to the Editor titled: A well validated risk stratification index predicts poor maternal and fetal outcomes
por: Khanna, Roopali, et al.
Publicado: (2021)

Patient and hospital building-related factors should also be considered for mitigation purposes
por: Gupta, Harish, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4lid94c5u30er7l5mjdjbbqtlj